Successful Discontinuation of the Placebo Arm and Provision of an Effective HIV Prevention Product After a Positive Interim Efficacy Result: The Partners PrEP Study Experience.

Publication Type:

Journal Article


Journal of acquired immune deficiency syndromes (1999), Volume 66, Issue 2, p.206-12 (2014)


2014, June 2014, Vaccine and Infectious Disease Division


Dissemination of research results to study participants and stakeholders and provision of proven effective products in the immediate post-trial period are core elements of the conduct of biomedical HIV prevention clinical trials. Few biomedical HIV prevention trials have demonstrated HIV protection with novel interventions, and thus, communication of positive trial results and provision of an effective product have not been tested in many situations.